TY  - GEN
AU  - Song,I-H
AU  - Heldmann,F
AU  - Rudwaleit,M
AU  - Listing,J
AU  - Appel,H
AU  - Braun,J
AU  - Sieper,J
TI  - Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial
SN  - 1529-0131
PY  - 2010///0614
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antigens, CD20
KW  - metabolism
KW  - Antirheumatic Agents
KW  - B-Lymphocytes
KW  - cytology
KW  - Drug Resistance
KW  - Female
KW  - Humans
KW  - Injections, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Rituximab
KW  - Spondylitis, Ankylosing
KW  - drug therapy
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/art.27383
ER  -